City

Cleveland (1)

Houston (1)

New York (1)

San Francisco (1)

Seattle (1)

Washington (1)

Overall Status

Completed (1)

Recruiting (1)

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Fred Hutchinson Cancer Center (1)

M.D. Anderson Cancer Center (1)

Collaborator

National Cancer Institute (NCI) (1)

National Heart, Lung, and Blood Institute (NHLBI) (1)

Study Documents

Intervention Type

biological (2)

drug (2)

procedure (2)

other (1)

radiation (1)

Funder Type

Other (2)

Study Type

Interventional (2)

acute erythroid leukemia

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,

Recruiting

Acute Erythroid Leukemia
+10 more

Fludarabine
+5 more

San Francisco, California
+5 more

Nov 1, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia

Completed

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
+14 more

Aldesleukin
+7 more

Houston, Texas

M D Anderson Cancer Center

Jul 31, 2022